Variant Bio Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Variant Bio's estimated annual revenue is currently $8.8M per year.(i)
  • Variant Bio's estimated revenue per employee is $155,000

Employee Data

  • Variant Bio has 57 Employees.(i)
  • Variant Bio grew their employee count by -3% last year.

Variant Bio's People

NameTitleEmail/Phone
1
VP, Biology ResearchReveal Email/Phone
2
VP Computational GeneticsReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
Chief Operating Officer & Chief Legal OfficerReveal Email/Phone
5
Chief Business OfficerReveal Email/Phone
6
Director FinanceReveal Email/Phone
7
Director BioinformaticsReveal Email/Phone
8
Associate DirectorReveal Email/Phone
9
Co-Founder, Chief Technology Officer, Chief Genomics OfficerReveal Email/Phone
10
Director Medical BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$3.3M4310%$101MN/A
#4
$5.7M3712%N/AN/A
#5
$7M4541%N/AN/A
#6
$1.7M22-8%N/AN/A
#7
$3.9M504%$10.1MN/A
#8
$1.9M12-73%N/AN/A
#9
$29.3M151-17%$148MN/A
#10
$2M1386%N/AN/A
Add Company

What Is Variant Bio?

Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.

keywords:N/A

N/A

Total Funding

57

Number of Employees

$8.8M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Variant Bio News

2022-04-17 - Nilit launches new bio-based Sensil variant

Nilit launches new bio-based Sensil variant ... widely used in the knitting sector, has launched a new variant of its premium Sensil brand.

2022-04-06 - HDT Bio Demonstrates RNA Vaccines Matched to SARS-CoV2 ...

In addition, the animal studies showed that even when not matched against variants, HDT Bio's RNA vaccine protects against lower respiratory...

2022-03-30 - HDT Bio Doses First Healthy Volunteer in US Phase 1 Trial of Next ...

The vaccine targets the Beta variant of SARS-CoV-2 and has a demonstrated ability to provide broad protection against multiple variants of the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.3M5763%N/A
#2
$7.2M5714%N/A
#3
$12.8M57-19%N/A
#4
$10.3M57-2%N/A
#5
$11.3M576%N/A